Ertugliflozin (Steglatro): A New Option for SGLT2 Inhibition.
Year: 2018
Type: article
Abstract: Steglatro (ertugliflozin) for glycemic control in adults with type-2 diabetes mellitus.
Source: Europe PMC (PubMed Central)
Authors: Nikolas Kovacich, Benjamin Chavez
Language: English
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2985116859